Profile data is unavailable for this security.
About the company
Abbott Laboratories is engaged in the discovery, development, manufacture, and sale of a diversified line of health care products. The Company operates through four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. Its Established Pharmaceutical Products segment includes gastroenterology products, women’s health products, cardiovascular and metabolic products, pain and central nervous system products and respiratory drugs and vaccines. Its Diagnostic Products segment includes core laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion medicine; molecular diagnostics polymerase chain reaction (PCR) instrument systems; point of care systems; rapid diagnostics lateral flow testing products, and informatics and automation solutions. Its Nutritional Products segment includes various forms of infant formula and follow-on formula, adult and other pediatric nutritional products and others.
- Revenue in USD (TTM)41.51bn
- Net income in USD5.80bn
- LocationAbbott Laboratories100 Abbott Park RdABBOTT PARK 60064-3500United StatesUSA
- Phone+1 (224) 667-6100
Mergers & acquisitions
|Acquired company||Deal status||Date||Date /|
|ABT:NYQ since |
|Cardiovascular Systems Inc||Deal completed||08 Feb 2023||08 Feb 2023Deal completed||-8.92%||840.49m|